Stereotaxis, Inc. (STXS) Financial Analysis & Valuation | Quarter Chart
Stereotaxis, Inc. (STXS)
STXSPrice: $2.43
Fair Value: 🔒
🔒score
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to c... more
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information s... more
Description
Shares
| Market Cap | $219.87M | Exchange | AMEX |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | David Leo Fischel C.A.I.A., |
| IPO Date | 2004-08-12 | CAGR | — |
| Employees | 139 | Website | www.stereotaxis.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
STXS chart loading...
Fundamentals
Technicals
| Enterprise Value | $281.24M | P/E Ratio | -9.38 |
| Forward P/E | -15.76 | PEG Ratio | — |
| P/S Ratio | 7.31 | P/B Ratio | 35.68 |
| P/CF Ratio | -26.46 | P/FCF Ratio | -25.94 |
| EPS | $-0.29 | EPS Growth 1Y | 2.02% |
| EPS Growth 3Y | 13.51% | EPS Growth 5Y | 201.09% |
| Revenue Growth 1Y | 19.61% | Gross Margin | 0.53% |
| Operating Margin | -0.8% | Profit Margin | -0.8% |
| ROE | -2.94% | ROA | -0.53% |
| ROCE | -0.96% | Current Ratio | 1.31 |
| Quick Ratio | 0.81 | Cash Ratio | 0.52 |
| Debt/Equity | 0.89 | Interest Coverage | — |
| Altman Z Score | -14.77 | Piotroski Score | 3 |